Badr University

buc.edu.eg

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

60

Active

18

Phase 3

4

Total enrollment

3,398

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
use of adapalene gel 0.1% and hyaluronic acid at bedtime1
use of adapalene gel 0.1% once daily at bedtime1
Metformin1
Pioglitazone1
Empagliflozin1
Statin1
Empagliflozin plus Statin1
Pioglitazone plus Atorvastatin1
Metformin gel Iontophoresis1
Alpha-Lipoic Acid (ALA)+PT1
Omega-3 cap+ PT1
Erythropoietin + Probiotic1
EPO1

Next readouts

  • 2025-10-21
  • 2026-01-01
  • 2026-02-01
  • 2026-03-15
  • 2026-04-15
  • 2026-06-01

Top conditions

  • Insulin Resistance2
  • Obesity2
  • Diabetes2
  • Hemiplegic Cerebral Palsy2
  • Class IV Dental Caries2
  • Alveolar Osteitis2
  • Chronic Kidney Disease2
  • Diplegia2

Frequently asked questions about Badr University

How many clinical trials does Badr University have on ClinicalTrials.gov?
Badr University is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
How many of Badr University's trials are in Phase 3?
4 of Badr University's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Badr University focus on?
Badr University's most-studied conditions on ClinicalTrials.gov are Insulin Resistance, Obesity, Diabetes, Hemiplegic Cerebral Palsy, Class IV Dental Caries.
When are Badr University's next clinical trial readouts?
Badr University has 6 upcoming primary-completion readouts tracked here; the soonest is “Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris”, expected around 2025-10-21.